川潤股份(002272.SZ):2022年儲能業務實現銷售收入4600餘萬元
格隆匯6月21日丨川潤股份(002272.SZ)近期在接待機構調研時表示,公司在儲能領域主要為客户提供儲能容器、換熱器、液冷集成等核心設備,並基於上述核心技術和設備為客户提供儲能項目EPC服務。公司儲能產品已實現國內多個項目的首台套應用,如全球首個二氧化碳儲能項目換熱設備、國內首台“兆瓦級軌道交通儲能裝置”等。公司2022年儲能業務實現銷售收入4600餘萬元。基於公司多年的技術積累和成熟的IPD產品開發能力,通過與行業客户長期穩定的合作關係,公司積極拓展儲能設備、儲能EPC項目業務,預期未來能取得較好發展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.